Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |